Author

Olga Mitelman

Observed name: O. Mitelman

Observed institution: Sarepta Therapeutics (United States)

OpenAlex ID: A5027201190

A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment

2021 · Olga Mitelman, for the investigators from the LNMRC Natural History study, et al. · Journal of Neuromuscular Diseases · 56

Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial Participation

2024 · Megan M. McNiff, Sheila Hawkins, et al. · Journal of Neuromuscular Diseases · 16

P311 Facioscapulohumeral muscular dystrophy European patient survey: assessing patient preferences in clinical trial participation

2023 · M. McNiff, S. Hawkins, et al. · Neuromuscular Disorders

EP.82A prospective study of eteplirsen treatment for Duchenne muscular dystrophy in routine clinical practice: study design and methodology

2019 · K. Tsai, R. Fischer, et al. · Neuromuscular Disorders

Works count: 4

Citation count: 71

H-index: 2

I10-index: 2